Docoh
Loading...

29 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
or Commercialization of Compounds or Products by Processa, its Affiliates or Sublicensees, including all Third-Party Claims involving death or bodily injury caused
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
, manufacturing defects, misuse or abuse associated with our product candidates could result in injury to a patient or even death. We cannot offer any … such cases. In addition, a liability claim may be brought against us even if our product candidates merely appear to have caused an injury. Product
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability suits in the future … if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us by consumers, health care
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
functions and processes. Any side effects, manufacturing defects, misuse or abuse associated with our product candidates could result in injury to a patient … appear to have caused an injury. Product liability claims may be brought against us by consumers, health care providers, pharmaceutical companies
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
effects, manufacturing defects, misuse or abuse associated with our product candidates could result in injury to a patient or even death. We cannot offer … under any such cases. In addition, a liability claim may be brought against us even if our product candidates merely appear to have caused an injury
S-1/A
EX-2.1
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
irreparable injury to the other parties for which damages, even if available, will not be an adequate remedy. Accordingly, each party hereby consents
S-1/A
EX-10.13
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
Affiliates or Sublicensees, including all Third Party Claims involving death or bodily injury caused or allegedly caused by the use of such a Compound
S-1/A
EX-10.11
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
, including all Third Party Claims involving death or bodily injury caused or allegedly caused by the use of such a Compound or Product, and even … with the provisions of this Agreement, such refusal or failure would result in irreparable injury to the Company or Yuhan as the case may be, the exact
S-1/A
EX-10.12
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
injury to the Company or Yuhan as the case may be, the exact amount of which would be difficult to ascertain or estimate and the remedies at law for which
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
Affiliates or Sublicensees, including all Third Party Claims involving death or bodily injury caused or allegedly caused by the use of such a Compound
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
all Third Party Claims involving death or bodily injury caused or allegedly caused by the use of such a Compound or Product, and even … with the provisions of this Agreement, such refusal or failure would result in irreparable injury to the Company or Yuhan as the case may be, the exact amount
8-K
EX-10.2
PCSA Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
to act, or to cause its Affiliates to act, in accordance with the provisions of this Agreement, such refusal or failure would result in irreparable injury
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
candidates could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability suits in the future … us even if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us by consumers, health care
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
with our product candidates could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability … be brought against us even if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
associated with our product candidates could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability … may be brought against us even if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
candidates could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability suits in the future … us even if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us by consumers, health
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
candidates could result in injury to a patient or even death. We cannot offer any assurance that we will not face product liability suits in the future … us even if our product candidates merely appear to have caused an injury. Product liability claims may be brought against us by consumers, health
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
be sued if any product we develop, including any of our product candidates, or any materials that we use in our products allegedly causes injury … for any of our product candidates or any future products that we may develop; injury to our reputation; withdrawal of clinical trial participants
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
products allegedly causes injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or sale. Any such product … claims may result in: decreased demand for any of our product candidates or any future products that we may develop; injury to our reputation
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
develop, including any of our product candidates, or any materials that we use in our products allegedly causes injury or is found to be otherwise … candidates or any future products that we may develop; injury to our reputation; withdrawal of clinical trial participants; substantial costs